Key result
Patients with schizophrenia, major depression, and bipolar disorder had significantly higher plasma lipoprotein(a) levels compared to healthy controls.
Why the study?
An increased incidence of adverse cardiovascular events has been reported in psychiatric patients, but the exact mechanisms underlying this association are still uncertain.
Are plasma levels of lipoprotein(a) elevated in patients with psychiatric disorders compared to healthy controls?
Case-Control (n=148)
Are plasma levels of lipoprotein(a) elevated in patients with psychiatric disorders compared to healthy controls?
Elevated Lp(a) levels in patients with severe psychiatric disorders may contribute to their increased cardiovascular risk.
Answers are grounded in this paper and cite their sources.
May prompt Lp(a) measurement in schizophrenia, depression, or bipolar disorder; leaves open causal contribution to excess cardiovascular risk.
An increased incidence of adverse cardiovascular events has been reported in psychiatric patients, but the exact mechanisms underlying this association are still uncertain. Elevated plasma level of lipoprotein(a) [Lp(a)] is an independent risk factor for atherothrombotic disease in the general population. To study the implications of Lp(a) in psychiatric patients, we measured the plasma levels of Lp(a) in 74 patients with psychiatric disorders (39 schizophrenia, 10 major depression, 13 bipolar disorder and 12 personality disorder) and 74 healthy controls. The Lp(a) levels of the patient groups with schizophrenia, major depression and bipolar disorder were significantly higher than that of the control group. The median Lp(a) value of these diagnostic groups was comparable with those reported in patients with prior atherothrombotic events. On the other hand, no differences were found among personality disorder and controls. Our findings suggest that the elevation of plasma Lp(a) may contribute to increased cardiovascular risk in several patients with psychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Emanuele et al. (2005) conducted a case-control in Psychiatric disorders (n=148). Psychiatric disorders vs. Healthy controls was evaluated on Plasma levels of lipoprotein(a). Patients with schizophrenia, major depression, and bipolar disorder had significantly higher plasma lipoprotein(a) levels compared to healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: